Nasal High-flow Oxygen Therapy During Acute Exercise in Fibrotic Interstitial Lung Disease

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 1, 2023

Primary Completion Date

January 31, 2025

Study Completion Date

January 31, 2025

Conditions

Interstitial Lung Disease (ILD)

Interventions

OTHER

Exercise testing

Each participant performs a constant work-rate exercise test (70% peak work rate) under the 4 experimental conditions (referred as arms).

Trial Locations (1)

Centre de Réadaptation Cardio-Respiratoire Dieulefit Santé, Dieulefit

All Listed Sponsors

lead

Dieulefit Santé Centre de Réadaptation

OTHER

NCT07129707 - Nasal High-flow Oxygen Therapy During Acute Exercise in Fibrotic Interstitial Lung Disease | Biotech Hunter | Biotech Hunter